- Home
- VRAX vs SGD Comparison
VRAX vs SGD Comparison
Compare VRAX & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- SGD
- Stock Information
- Founded
- VRAX 2013
- SGD 2021
- Country
- VRAX United Kingdom
- SGD United States
- Employees
- VRAX N/A
- SGD N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SGD
- Sector
- VRAX Health Care
- SGD
- Exchange
- VRAX Nasdaq
- SGD Nasdaq
- Market Cap
- VRAX 4.4M
- SGD 4.4M
- IPO Year
- VRAX 2022
- SGD N/A
- Fundamental
- Price
- VRAX $0.67
- SGD $1.60
- Analyst Decision
- VRAX Strong Buy
- SGD
- Analyst Count
- VRAX 1
- SGD 0
- Target Price
- VRAX $3.00
- SGD N/A
- AVG Volume (30 Days)
- VRAX 165.6K
- SGD 362.9K
- Earning Date
- VRAX 01-01-0001
- SGD 11-22-2025
- Dividend Yield
- VRAX N/A
- SGD N/A
- EPS Growth
- VRAX N/A
- SGD N/A
- EPS
- VRAX N/A
- SGD N/A
- Revenue
- VRAX $6,331.00
- SGD $1,536,255.00
- Revenue This Year
- VRAX $217,274.83
- SGD N/A
- Revenue Next Year
- VRAX N/A
- SGD N/A
- P/E Ratio
- VRAX N/A
- SGD N/A
- Revenue Growth
- VRAX N/A
- SGD 1570.24
- 52 Week Low
- VRAX $0.52
- SGD $0.65
- 52 Week High
- VRAX $3.62
- SGD $6.00
- Technical
- Relative Strength Index (RSI)
- VRAX 53.05
- SGD 61.95
- Support Level
- VRAX $0.64
- SGD $1.31
- Resistance Level
- VRAX $0.68
- SGD $1.55
- Average True Range (ATR)
- VRAX 0.03
- SGD 0.16
- MACD
- VRAX 0.01
- SGD 0.01
- Stochastic Oscillator
- VRAX 81.11
- SGD 91.67
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.